{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:55:41Z","timestamp":1790823341844,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T00:00:00Z","timestamp":1568419200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T00:00:00Z","timestamp":1568419200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004792","name":"Minist\u00e8re de l'Enseignement Sup\u00e9rieur et de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-16-RHUS-0009"],"award-info":[{"award-number":["ANR-16-RHUS-0009"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s12975-019-00733-8","type":"journal-article","created":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T06:03:02Z","timestamp":1568440982000},"page":"481-495","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Immune Responses and Anti-inflammatory Strategies in a Clinically Relevant Model of Thromboembolic Ischemic Stroke with Reperfusion"],"prefix":"10.1007","volume":"11","author":[{"given":"Antoine","family":"Drieu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izaskun","family":"Buendia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Levard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"H\u00e9lie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Brodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Vivien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6120-4053","authenticated-orcid":false,"given":"Marina","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,14]]},"reference":[{"key":"733_CR1","doi-asserted-by":"publisher","unstructured":"Feigin VL, Nguyen G, Cercy K, Johnson CO, Alam T, Parmar PG, et al. Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016. The GBD 2016 Lifetime Risk of Stroke Collaborators. N Engl J Med. 2018;379:2429\u20132437. \nhttps:\/\/doi.org\/10.1056\/NEJMoa1804492","DOI":"10.1056\/NEJMoa1804492"},{"key":"733_CR2","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1161\/01.STR.0000258112.14918.24","volume":"38","author":"J-H Rha","year":"2007","unstructured":"Rha J-H, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke. 2007;38:967\u201373.","journal-title":"Stroke"},{"key":"733_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0166-2236(99)01401-0","volume":"22","author":"U Dirnagl","year":"1999","unstructured":"Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999;22:391\u20137.","journal-title":"Trends Neurosci"},{"key":"733_CR4","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","volume":"359","author":"W Hacke","year":"2008","unstructured":"Hacke W, Kaste M, Bluhmki E, Brozman M, D\u00e1valos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317\u201329.","journal-title":"N Engl J Med"},{"key":"733_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1706442","volume":"378","author":"RG Nogueira","year":"2018","unstructured":"Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378:11\u201321.","journal-title":"N Engl J Med"},{"key":"733_CR6","doi-asserted-by":"publisher","first-page":"175628641878985","DOI":"10.1177\/1756286418789854","volume":"11","author":"A Drieu","year":"2018","unstructured":"Drieu A, Levard D, Vivien D, Rubio M. Anti-inflammatory treatments for stroke: from bench to bedside. Ther Adv Neurol Disord. 2018;11:1756286418789854.","journal-title":"Ther Adv Neurol Disord"},{"key":"733_CR7","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/jth.12487","volume":"12","author":"M Gauberti","year":"2014","unstructured":"Gauberti M, Martinez de Lizarrondo S, Orset C, Vivien D. Lack of secondary microthrombosis after thrombin-induced stroke in mice and non-human primates. J Thromb Haemost. 2014;12:409\u201314.","journal-title":"J Thromb Haemost"},{"key":"733_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1750-3639.2012.00614.x","volume":"23","author":"W Zhou","year":"2013","unstructured":"Zhou W, Liesz A, Bauer H, Sommer C, Lahrmann B, Valous N, et al. Postischemic brain infiltration of leukocyte subpopulations differs among murine permanent and transient focal cerebral ischemia models. Brain Pathol. 2013;23:34\u201344.","journal-title":"Brain Pathol"},{"key":"733_CR9","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1161\/STROKEAHA.108.534503","volume":"40","author":"M Gelderblom","year":"2009","unstructured":"Gelderblom M, Leypoldt F, Steinbach K, Behrens D, Choe C-U, Siler DA, et al. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke. 2009;40:1849\u201357.","journal-title":"Stroke"},{"key":"733_CR10","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/jcbfm.2013.217","volume":"34","author":"HX Chu","year":"2014","unstructured":"Chu HX, Kim HA, Lee S, Moore JP, Chan CT, Vinh A, et al. Immune cell infiltration in malignant middle cerebral artery infarction: comparison with transient cerebral ischemia. J Cereb Blood Flow Metab. 2014;34:450\u20139.","journal-title":"J Cereb Blood Flow Metab"},{"key":"733_CR11","doi-asserted-by":"publisher","unstructured":"Cai, W., Liu, S., Hu, M. et al. Functional dynamics of neutrophils after ischemic stroke. Transl Stroke Res. 2019. \nhttps:\/\/doi.org\/10.1007\/s12975-019-00694-y","DOI":"10.1007\/s12975-019-00694-y"},{"key":"733_CR12","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1161\/STROKEAHA.107.487520","volume":"38","author":"C Orset","year":"2007","unstructured":"Orset C, Macrez R, Young AR, Panthou D, Angles-Cano E, Maubert E, et al. Mouse model of in situ thromboembolic stroke and reperfusion. Stroke. 2007;38:2771\u20138.","journal-title":"Stroke"},{"key":"733_CR13","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1182\/blood-2013-12-543074","volume":"123","author":"A Le Behot","year":"2014","unstructured":"Le Behot A, Gauberti M, Martinez De Lizarrondo S, Montagne A, Lemarchand E, Repesse Y, et al. GpIb\u03b1-VWF blockade restores vessel patency by dissolving platelet aggregates formed under very high shear rate in mice. Blood. 2014;123:3354\u201363.","journal-title":"Blood"},{"key":"733_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jns.2011.02.024","volume":"304","author":"K Kimura","year":"2011","unstructured":"Kimura K, Sakamoto Y, Iguchi Y, Shibazaki K. Serial changes in ischemic lesion volume and neurological recovery after t-PA therapy. J Neurol Sci. 2011;304:35\u20139.","journal-title":"J Neurol Sci"},{"key":"733_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/jmri.20363","volume":"22","author":"J-B Pialat","year":"2005","unstructured":"Pialat J-B, Wiart M, Nighoghossian N, Adeleine P, Derex L, Hermier M, et al. Evolution of lesion volume in acute stroke treated by intravenous t-PA. J Magn Reson Imaging. 2005;22:23\u20138.","journal-title":"J Magn Reson Imaging"},{"key":"733_CR16","doi-asserted-by":"publisher","unstructured":"Effect of intravenous recombinant tissue plasminogen activator on ischemic stroke lesion size measured by computed tomography. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group. Stroke. 2000;31(12):2912\u20139. \nhttps:\/\/doi.org\/10.1161\/01.str.31.12.2912","DOI":"10.1161\/01.str.31.12.2912"},{"key":"733_CR17","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1161\/STROKEAHA.116.012238","volume":"47","author":"C Orset","year":"2016","unstructured":"Orset C, Haelewyn B, Allan SM, Ansar S, Campos F, Cho TH, et al. Efficacy of alteplase in a mouse model of acute ischemic stroke: a retrospective pooled analysis. Stroke. 2016;47:1312\u20138.","journal-title":"Stroke"},{"key":"733_CR18","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1093\/brain\/aww260","volume":"140","author":"A Quenault","year":"2017","unstructured":"Quenault A, Martinez de Lizarrondo S, Etard O, Gauberti M, Orset C, Haelewyn B, et al. Molecular magnetic resonance imaging discloses endothelial activation after transient ischaemic attack. Brain. 2017;140:146\u201357.","journal-title":"Brain"},{"key":"733_CR19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3389\/fimmu.2015.00249","volume":"6","author":"M Greter","year":"2015","unstructured":"Greter M, Lelios I, Croxford AL. Microglia versus myeloid cell nomenclature during brain inflammation. Front Immunol. 2015;6:249.","journal-title":"Front Immunol"},{"key":"733_CR20","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1161\/STROKEAHA.110.606293","volume":"42","author":"R Macrez","year":"2011","unstructured":"Macrez R, Obiang P, Gauberti M, Roussel B, Baron A, Parcq J, et al. Antibodies preventing the interaction of tissue-type plasminogen activator with N-methyl-D-aspartate receptors reduce stroke damages and extend the therapeutic window of thrombolysis. Stroke. 2011;42:2315\u201322.","journal-title":"Stroke"},{"key":"733_CR21","doi-asserted-by":"publisher","first-page":"299ra121","DOI":"10.1126\/scitranslmed.aaa9853","volume":"7","author":"G Llovera","year":"2015","unstructured":"Llovera G, Hofmann K, Roth S, Salas-P\u00e9rdomo A, Ferrer-Ferrer M, Perego C, et al. Results of a preclinical randomized controlled multicenter trial (pRCT): anti-CD49d treatment for acute brain ischemia. Sci Transl Med. 2015;7:299ra121.","journal-title":"Sci Transl Med"},{"key":"733_CR22","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1161\/STROKEAHA.115.011238","volume":"47","author":"SF De Meyer","year":"2016","unstructured":"De Meyer SF, Denorme F, Langhauser F, Geuss E, Fluri F, Kleinschnitz C. Thromboinflammation in stroke brain damage. Stroke. 2016;47:1165\u201372.","journal-title":"Stroke."},{"key":"733_CR23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3389\/fmed.2018.00195","volume":"5","author":"M Gauberti","year":"2018","unstructured":"Gauberti M, Potzeha F, Vivien D, Martinez de Lizarrondo S. Impact of bradykinin generation during thrombolysis in ischemic stroke. Front Med (Lausanne). 2018;5:195.","journal-title":"Front Med (Lausanne)"},{"key":"733_CR24","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1161\/STROKEAHA.109.556852","volume":"40","author":"LS Machado","year":"2009","unstructured":"Machado LS, Sazonova IY, Kozak A, Wiley DC, El-Remessy AB, Ergul A, et al. Minocycline and tissue-type plasminogen activator for stroke: assessment of interaction potential. Stroke. 2009;40:3028\u201333.","journal-title":"Stroke"},{"key":"733_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.brainres.2005.02.062","volume":"1044","author":"N Morimoto","year":"2005","unstructured":"Morimoto N, Shimazawa M, Yamashima T, Nagai H, Hara H. Minocycline inhibits oxidative stress and decreases in vitro and in vivo ischemic neuronal damage. Brain Res. 2005;1044:8\u201315.","journal-title":"Brain Res"},{"key":"733_CR26","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1001\/archneurol.2010.191","volume":"67","author":"JM Plane","year":"2010","unstructured":"Plane JM, Shen Y, Pleasure DE, Deng W. Prospects for minocycline neuroprotection. Arch Neurol. 2010;67:1442\u20138.","journal-title":"Arch Neurol"},{"key":"733_CR27","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1007\/s00415-018-8935-3","volume":"265","author":"K Malhotra","year":"2018","unstructured":"Malhotra K, Chang JJ, Khunger A, Blacker D, Switzer JA, Goyal N, et al. Minocycline for acute stroke treatment: a systematic review and meta-analysis of randomized clinical trials. J Neurol. 2018;265:1871\u20139.","journal-title":"J Neurol"},{"key":"733_CR28","doi-asserted-by":"publisher","first-page":"e525","DOI":"10.1038\/cddis.2013.54","volume":"4","author":"K Kobayashi","year":"2013","unstructured":"Kobayashi K, Imagama S, Ohgomori T, Hirano K, Uchimura K, Sakamoto K, et al. Minocycline selectively inhibits M1 polarization of microglia. Cell Death Dis. 2013;4:e525.","journal-title":"Cell Death Dis"},{"key":"733_CR29","doi-asserted-by":"publisher","first-page":"11499","DOI":"10.1038\/ncomms11499","volume":"7","author":"G Szalay","year":"2016","unstructured":"Szalay G, Martinecz B, L\u00e9n\u00e1rt N, K\u00f6rnyei Z, Orsolits B, Jud\u00e1k L, et al. Microglia protect against brain injury and their selective elimination dysregulates neuronal network activity after stroke. Nat Commun. 2016;7:11499.","journal-title":"Nat Commun"},{"key":"733_CR30","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1212\/01.wnl.0000277487.04281.db","volume":"69","author":"Y Lampl","year":"2007","unstructured":"Lampl Y, Boaz M, Gilad R, Lorberboym M, Dabby R, Rapoport A, et al. Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology. 2007;69:1404\u201310.","journal-title":"Neurology"},{"key":"733_CR31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4103\/0028-3886.93584","volume":"60","author":"MV Padma Srivastava","year":"2012","unstructured":"Padma Srivastava MV, Bhasin A, Bhatia R, Garg A, Gaikwad S, Prasad K, et al. Efficacy of minocycline in acute ischemic stroke: a single-blinded, placebo-controlled trial. Neurol India. 2012;60:23\u20138.","journal-title":"Neurol India"},{"key":"733_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/ane.12296","volume":"131","author":"MR Amiri-Nikpour","year":"2015","unstructured":"Amiri-Nikpour MR, Nazarbaghi S, Hamdi-Holasou M, Rezaei Y. An open-label evaluator-blinded clinical study of minocycline neuroprotection in ischemic stroke: gender-dependent effect. Acta Neurol Scand. 2015;131:45\u201350.","journal-title":"Acta Neurol Scand"},{"key":"733_CR33","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1161\/STROKEAHA.113.000780","volume":"44","author":"E Kohler","year":"2013","unstructured":"Kohler E, Prentice DA, Bates TR, Hankey GJ, Claxton A, van Heerden J, et al. Intravenous minocycline in acute stroke: a randomized, controlled pilot study and meta-analysis. Stroke. 2013;44:2493\u20139.","journal-title":"Stroke"},{"key":"733_CR34","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1093\/brain\/awr008","volume":"134","author":"A Liesz","year":"2011","unstructured":"Liesz A, Zhou W, Mracsk\u00f3 \u00c9, Karcher S, Bauer H, Schwarting S, et al. Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain. 2011;134:704\u201320.","journal-title":"Brain"},{"key":"733_CR35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S1474-4422(16)30357-X","volume":"16","author":"J Elkins","year":"2017","unstructured":"Elkins J, Veltkamp R, Montaner J, Johnston SC, Singhal AB, Becker K, et al. Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial. Lancet Neurol. 2017;16:217\u201326.","journal-title":"Lancet Neurol"},{"key":"733_CR36","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S0140-6736(10)60834-3","volume":"376","author":"MJ O\u2019Donnell","year":"2010","unstructured":"O\u2019Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376:112\u201323.","journal-title":"Lancet"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-019-00733-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12975-019-00733-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-019-00733-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T23:26:36Z","timestamp":1599953196000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12975-019-00733-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,14]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["733"],"URL":"https:\/\/doi.org\/10.1007\/s12975-019-00733-8","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,14]]},"assertion":[{"value":"19 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}